Clinical Trial Update: Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D [Phase 2]

View source ↗

Summary

Phase 2 trial results for Glucagon Ready-to-Use (RTU) evaluating prevention of exercise-induced hypoglycemia in adults with Type 1 diabetes; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• Glucagon Ready-to-Use (RTU) (glucagon)

Snippet

Sponsor: Xeris Pharmaceuticals | Conditions: Hypoglycemia | Phase 2 | Status: COMPLETED | Results posted: 2023-08-25